Arcutis Biotherapeutics saw the highest growth of 156% in patent filings in October and 199% in grants in December in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 156% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Arcutis Biotherapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Arcutis Biotherapeutics has been focused on protecting inventions in United States(US) with 11 publications in Q4 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 64% filings and 50% grants. The United States(US), South Korea(KR), European Patent Office(EPO), and China(CN) patent Office are among the top ten patent offices where Arcutis Biotherapeutics is filings its patents. Among the top granted patent authorities, Arcutis Biotherapeutics has 50% of its grants in United States(US), 25% in European Patent Office(EPO) and 25% in Israel(IL).

Johnson & Johnson and F. Hoffmann-La Roche could be the strongest competitors for Arcutis Biotherapeutics

Patents related to climate change and nanomedicine lead Arcutis Biotherapeutics's portfolio

Arcutis Biotherapeutics has the highest number of patents in climate change followed by, nanomedicine and addiction. For climate change, nearly 67% of patents were filed and no patents were granted in Q4 2023.

Atopic dermatitis (atopic eczema) related patents lead Arcutis Biotherapeutics portfolio followed by psoriasis, and bacterial infections

Arcutis Biotherapeutics has highest number of patents in atopic dermatitis (atopic eczema) followed by psoriasis, bacterial infections, alopecia areata, and skin inflammation. For atopic dermatitis (atopic eczema), nearly 10% of patents were filed and 17% of patents were granted in Q4 2023.

For comprehensive analysis of Arcutis Biotherapeutics's filings and grants, buy the databook here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.